Amarin (AMRN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings ...

Aspen Pharmacare posted a 5% rise in half-year earnings on Monday and said it expects double-digit revenue and core profit ...

Jefferies analyst David Stanton maintained a Buy rating on Neuren Pharmaceuticals Limited (NURPF – Research Report) today and set a price target of A$27.40. The company’s shares closed last ...

Craig-Hallum analyst Greg Palm maintained a Buy rating on Phathom Pharmaceuticals (PHAT – Research Report) today. The company’s shares opened today at $5.65. See what stocks are receiving ...

The month of November saw a number of notable hires and personnel moves in biotech and pharma. Read on for a round-up of some of the biggest moves that crossed our desks. AstraZeneca hires new SVP ...

As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.

Repurchase of Common & Preferred Stk. Repurchase of Common & Preferred Stk.

IPC Indice de Precios Y Cotizaciones 52,816.43 107.03 0.20% ...

After hours: March 7 at 4:05:05 PM EST Loading Chart for ABOS ...

What does Nifty Pharma represent? Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends ...